Gf Fund Management Co. Ltd. Arcellx, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Arcellx, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,136 shares of ACLX stock, worth $102,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,136
Previous 1,193
4.78%
Holding current value
$102,217
Previous $97.9 Million
24.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
233Shares Held
51.7MCall Options Held
85.4KPut Options Held
113K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.35MShares$572 Million0.32% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$418 Million12.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$367 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$316 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.05MShares$274 Million15.63% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.94B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...